{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:52:19Z","timestamp":1782258739675,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.ejmech.2013.04.035","type":"journal-article","created":{"date-parts":[[2013,5,9]],"date-time":"2013-05-09T05:47:21Z","timestamp":1368078441000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: Design, synthesis, inhibitory activity and 3D-QSAR analysis"],"prefix":"10.1016","volume":"66","author":[{"given":"Zhong-Chang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Juan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-An","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Yue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Tao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Li","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Liang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2013.04.035_bib1","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.bmc.2011.02.015","article-title":"Purification and inhibition studies with anions and sulfonamides of an \u03b1-carbonic anhydrase from the Antarctic seal Leptonychotes weddellii","volume":"19","author":"Cincinelli","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib2","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1021\/jm061320h","article-title":"Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked o-glycosides of benzene sulfonamides","volume":"50","author":"Wilkinson","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib3","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1021\/jm901888x","article-title":"Sulfonamide linked neoglycoconjugates-a new class of inhibitors for cancer-associated carbonic anhydrases","volume":"53","author":"Lopez","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib4","doi-asserted-by":"crossref","first-page":"27799","DOI":"10.1074\/jbc.M800938200","article-title":"Biochemical characterization of CA IX: one of the\u00a0most active carbonic anhydrase isozymes","volume":"283","author":"Hilvo","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2013.04.035_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.gde.2010.10.006","article-title":"Hypoxia and energetic tumour metabolism","volume":"21","author":"Brahimi-Horn","year":"2011","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.ejmech.2013.04.035_bib7","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1021\/jm200892s","volume":"54","author":"Morris","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10555-007-9064-0","article-title":"Regulation of tumor pH and the role of carbonic anhydrase 9","volume":"26","author":"Swietach","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ejmech.2013.04.035_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Svastova","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2013.04.035_bib10","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show inhibitory activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0968-0896(00)00288-1","article-title":"Carbonic anhydrase inhibitors: sulfonamides as antitumor agents","volume":"9","author":"Supuran","year":"2001","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib12a","first-page":"7075","article-title":"Hypoxia-inducible regulation of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2013.04.035_bib12b","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.bjc.6600936","article-title":"Diagnostics, prognostics and therapeutic implications of carbonic anhydrases in cancer","volume":"89","author":"Potter","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2013.04.035_bib12c","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2013.04.035_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1081\/CNV-200027148","article-title":"Tumor-activated prodrugs. A new approach to cancer therapy","volume":"22","author":"Denny","year":"2004","journal-title":"Cancer Invest."},{"key":"10.1016\/j.ejmech.2013.04.035_bib14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1582-4934.2009.00994.x","article-title":"Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer","volume":"14","author":"Chiche","year":"2010","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.ejmech.2013.04.035_bib15","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1021\/jm00091a018","volume":"35","author":"Yoshino","year":"1992","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1568009023334060","article-title":"Sulfonamides and sulfonylated derivatives as anticancer agents","volume":"2","author":"Casini","year":"2002","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejmech.2013.04.035_bib17","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1073\/pnas.96.10.5686","article-title":"Proc. Selective, covalent modification of \u03b2-tubulin residue Cys-239 by T138067, an antitumor agent with in\u00a0vivo efficacy against\u00a0multidrug-resistant tumors","volume":"96","author":"Shan","year":"1999","journal-title":"Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2013.04.035_bib18","first-page":"6942","article-title":"HMN-176, an active metabolite of the synthetic antitumor agent HMN-214, restores chemosensitivity to multidrug-resistant cells by targeting the transcription factor NF-Y","volume":"63","author":"Tanaka","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2013.04.035_bib19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1517\/13543776.10.5.575","article-title":"Carbonic anhydrase inhibitors and their therapeutic potential","volume":"10","author":"Supuran","year":"2000","journal-title":"Exp. Opin. Ther. Patents"},{"key":"10.1016\/j.ejmech.2013.04.035_bib20","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.287.5460.1960","article-title":"Drug discovery: a historical perspective","volume":"287","author":"Drew","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2013.04.035_bib21","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.bmcl.2011.05.061","article-title":"Synthesis of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide as anticancer and anti-inflammatory agents","volume":"21","author":"Bashir","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/jm901287j","article-title":"Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins","volume":"53","author":"Maresca","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10025","volume":"23","author":"Supuran","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2013.04.035_bib24","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1021\/jm0600287","volume":"49","author":"Thiry","year":"2006","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib25","first-page":"2011","volume":"28","author":"Gao","year":"2008","journal-title":"Chin. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib26","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib27a","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2013.04.035_bib27b","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2174\/092986710790979999","article-title":"Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII","volume":"17","author":"Ozensoy","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib27c","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbapap.2009.07.027","article-title":"Carbonic anhydrase IX: biochemical and crystallographic characterization of a novel antitumor target","volume":"1804","author":"De Simone","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2013.04.035_bib27d","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2013.04.035_bib28","doi-asserted-by":"crossref","first-page":"8371","DOI":"10.1039\/c0cc02707c","article-title":"Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency","volume":"46","author":"Pacchiano","year":"2010","journal-title":"Chem. Commun. (Cambridge, U. K.)"},{"key":"10.1016\/j.ejmech.2013.04.035_bib29","series-title":"The Pharmacological Basis of the Rapeutics","first-page":"999","article-title":"Drugs used in the chemotherapy of protozoal infections","author":"Webster","year":"1990"},{"key":"10.1016\/j.ejmech.2013.04.035_bib30","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/aoc.1813","article-title":"Synthesis, spectroscopic characterization, antimicrobial, pesticidal and nematicidal activity of some nitrogen-oxygen and nitrogen\u2013sulfur donor coumarins based ligands and their organotin(IV) complexes","volume":"25","author":"Dawara","year":"2011","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1155\/2007\/237645","article-title":"Synthesis, characterization and primary antimicrobial, antifungal activity evaluation of Schiff bases of 4-chloro- (3-substituted-phenylimino)-methyl-[2H]-chromene-2-one","volume":"7","author":"Kasabe","year":"2010","journal-title":"E-Journal Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib33","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib34a","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1021\/jm030911u","article-title":"Carbonic anhydrase inhibitors: inhibition of trans-membrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates","volume":"46","author":"Winum","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib34b","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1021\/jm0501073","article-title":"Carbonic anhydrase inhibitors. Sulfonamides inhibit isozyme IX mediated acidification of hypoxic tumors. Fluorescent sulfonamides design as probes of membrane-bound carbonic anhydrase isozymes involvement in tumorigenesis","volume":"48","author":"Cecchi","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib34c","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1021\/jm061320h","article-title":"Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked o-glycosides of benzene sulfonamides","volume":"50","author":"Wilkinson","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.04.035_bib35","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1021\/jm0707774","article-title":"New novobiocin analogues as antitumor agents in breast cancer cells and potential inhibitors of heat shock protein 90","volume":"50","author":"Bras","year":"2007","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413002675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413002675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T11:15:55Z","timestamp":1715339755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523413002675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":42,"alternative-id":["S0223523413002675"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.04.035","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: Design, synthesis, inhibitory activity and 3D-QSAR analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}